Cargando…

A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity

Anthracyclines are effective agents generally used to treat solid-tumor and hematologic malignancies. The use of anthracyclines for over 40 years has improved cancer survival statistics. Nevertheless, the clinical utility of anthracyclines is limited by its dose-dependent cardiotoxicity that adverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xinyu, Liu, Nian, Li, Xinye, Yang, Yihan, Wang, Xiaofeng, Li, Linling, Jiang, Le, Gao, Yonghong, Tang, Hebin, Tang, Yong, Xing, Yanwei, Shang, Hongcai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963334/ https://www.ncbi.nlm.nih.gov/pubmed/29867456 http://dx.doi.org/10.3389/fphar.2018.00444

Ejemplares similares

Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
por: Yang, Xinyu, et al.
Publicado: (2018)

Traditional Chinese Medicine for Bradyarrhythmia: Evidence and Potential Mechanisms
por: Liu, Shuo, et al.
Publicado: (2018)

Gender Differences in Prognosis and Risk Stratification of Brugada Syndrome: A Pooled Analysis of 4,140 Patients From 24 Clinical Trials
por: Yuan, Mengchen, et al.
Publicado: (2018)

The Role of Traditional Chinese Medicine in the Regulation of Oxidative Stress in Treating Coronary Heart Disease
por: Yang, Xinyu, et al.
Publicado: (2019)

Efficacy and Safety of NaoShuanTong Capsule in the Treatment of Ischemic Stroke: A Meta-Analysis
por: Zhang, Hanlai, et al.
Publicado: (2019)

Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation
por: Yang, Xinyu, et al.
Publicado: (2020)

Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
por: Qiu, Ruijin, et al.
Publicado: (2020)

Assessing Clinical Effects of Traditional Chinese Medicine Interventions: Moving Beyond Randomized Controlled Trials
por: Sun, Xin, et al.
Publicado: (2021)

Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review
por: Li, Xinye, et al.
Publicado: (2020)

Meta-Analysis of Risk Stratification of SCN5A With Brugada Syndrome: Is SCN5A Always a Marker of Low Risk?
por: Yang, Yihan, et al.
Publicado: (2019)

Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
por: Huang, Junqi, et al.
Publicado: (2022)

Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review
por: Li, Yubing, et al.
Publicado: (2023)

Antidepressant Active Ingredients From Chinese Traditional Herb Panax Notoginseng: A Pharmacological Mechanism Review
por: Li, Yanwei, et al.
Publicado: (2022)

Network Patterns of Herbal Combinations in Traditional Chinese Clinical Prescriptions
por: Wang, Ning, et al.
Publicado: (2021)

The Application of UHPLC-HRMS for Quality Control of Traditional Chinese Medicine
por: Ma, Jieyao, et al.
Publicado: (2022)

Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
por: An, Na, et al.
Publicado: (2019)

Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management
por: Jiang, Wei, et al.
Publicado: (2022)

The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside
por: Li, Yukun, et al.
Publicado: (2022)

The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Effect of Traditional Chinese Medicine on the Cardiovascular Diseases
por: Jiang, Yang, et al.
Publicado: (2022)

Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach
por: Shen, Yunfu, et al.
Publicado: (2022)

Effects of Wenxin Keli on Cardiac Hypertrophy and Arrhythmia via Regulation of the Calcium/Calmodulin Dependent Kinase II Signaling Pathway
por: Yang, Xinyu, et al.
Publicado: (2017)

Tai Chi as a Therapy of Traditional Chinese Medicine on Reducing Blood Pressure: A Systematic Review of Randomized Controlled Trials
por: Pan, Xiandu, et al.
Publicado: (2021)

Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Yang, Xinyu, et al.
Publicado: (2017)

Advances in the treatment of pancreatic cancer with traditional Chinese medicine
por: Zhang, Yanhua, et al.
Publicado: (2023)

Kidney tonifying traditional Chinese medicine: Potential implications for the prevention and treatment of osteoporosis
por: Duan, Yan, et al.
Publicado: (2023)

Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies
por: Yang, Xinyu, et al.
Publicado: (2017)

Cyclovirobuxine D, a cardiovascular drug from traditional Chinese medicine, alleviates inflammatory and neuropathic pain mainly via inhibition of voltage-gated Ca(v)3.2 channels
por: Su, Deyuan, et al.
Publicado: (2022)

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
por: Wu, Min, et al.
Publicado: (2020)

The signaling pathways of traditional Chinese medicine in treating diabetic retinopathy
por: Li, Wencan, et al.
Publicado: (2023)

Application of natural antioxidants from traditional Chinese medicine in the treatment of spinal cord injury
por: Huang, Zhihua, et al.
Publicado: (2022)

Mechanism of ferroptosis in traditional chinese medicine for clinical treatment: A review
por: Liu, Jiajiao, et al.
Publicado: (2023)

Pooled Analysis of Risk Stratification of Spontaneous Type 1 Brugada ECG: Focus on the Influence of Gender and EPS
por: Li, Xinye, et al.
Publicado: (2019)

Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine
por: Tian, Rui, et al.
Publicado: (2023)

Assesment of Adulterated Traditional Chinese Medicines in China: 2003-2017
por: Xu, Mingzhe, et al.
Publicado: (2019)

The potential of Valeriana as a traditional Chinese medicine: traditional clinical applications, bioactivities, and phytochemistry
por: Li, Jianchun, et al.
Publicado: (2022)

Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022)

Mechanism and Potential Target of Blood-Activating Chinese Botanical Drugs Combined With Anti-Platelet Drugs: Prevention and Treatment of Atherosclerotic Cardiovascular Diseases
por: Li, Dan, et al.
Publicado: (2022)

Potential application of traditional Chinese medicine in cerebral ischemia—Focusing on ferroptosis
por: Zhao, Fengyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vt2jo7ncnevjfeemt9a2b334ri